PANSİTOPENİ / BİSİTOPENİSİ OLAN ÇOCUKLARIN KLİNİK VE ETİYOLOJİK AÇIDAN DEĞERLENDİRİLMESİ

Giriş: Pansitopeni ve bisitopeni, çocukluk çağında sık karşılaşılan önemli klinik durumlardır. Benign ya da malignnedenlere bağlı olarak görülebilmektedirler. Bu çalışmada pansitopeni ve bisitopenisi olan hastaların klinik velaboratuvar olarak değerlendirilmesi ve etiyolojik nedenlerin belirlenmesi amaçlanmıştır.Gereç ve Yöntem: Ocak 2018-Ocak 2020 tarihleri arasında Çocuk Hematoloji Bölümü’nde izlenen, yaşları 3 ay18 yaş arasında olan, yeni ortaya çıkan pansitopeni/bisitopenisi olan 108 hasta çalışmaya alındı. Hastalarındetaylı öykü, fizik muayene bulguları, periferik yayma ve kemik iliği incelemesi de dahil laboratuvar bulgularıkaydedildi.Bulgular: Hastalarda kız/erkek oranı 56/52, yaş ortalaması 6,2 yıl idi. Hastaların 67’sinde (%62) bisitopeni,41’inde (%38) pansitopeni mevcuttu. En sık başvuru yakınmaları ateş (%63,9), halsizlik (%28,7) ve solunum yoluenfeksiyonu semptomları (%20,3) idi. Fizik muayenede en sık saptanan bulguların solukluk (%50), hepatomegali(%27,8) ve splenomegali (%26,8) olduğu görüldü. Hastaların %86’sında trombositopeni, %76,9’unda anemi,%72,2’sinde lökopeni ya da nötropeni mevcuttu. Bisitopenisi olan hastaların %41,9’unda anemi vetrombositopeni, %37,3’ünde lökopeni/nötropeni ve trombositopeni, %20,8’inde anemi ve lökopeni/nötropenibirlikte görüldü. Elli üç (%49,1) hastaya kemik iliği incelemesi yapıldı. En sık pansitopeni/bisitopeni nedenlerininenfeksiyon (%37,6), akut lösemi (%29,6) ve megaloblastik anemi (%17,5) olduğu görüldü.Sonuç: Pansitopeni/bisitopeni saptanan hastalarda klinik bulgular, tam kan sayımı ve periferik yayma bulgularıönemli ipuçları vermektedir. Malignensiden korkulsa da geri dönüşümlü benign nedenler etiyolojide çoğunluğuoluşturmaktadır

CLINICAL AND ETIOLOGICAL EVALUATION OF CHILDREN WITH PANCYTOPENIA / BICYTOPENIA

Introduction: Pancytopenia and bicytopenia are important clinical conditions that can be encountered frequently in childhood. Both benign or malignant conditions can cause pancytopenia and bicytopenia. In this study, it was aimed to evaluate clinical and laboratory findings in patients with pancytopenia and bicytopenia and to determine etiological causes. Material and Method: 108 newly diagnosed pancytopenia/bicytopenia patients aged between 3 months and 18 years who were followed up in the Department of Pediatric Hematology between January 2018 and January 2020 were included in the study. Laboratory findings including a detailed history, physical examination findings, peripheral smear and bone marrow examination were recorded. 80 İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi (Medical Journal of İzmir Hospital) Results: The female /male ratio was 56/52 in, and the average age was 6.2 years. Bicytopenia was present in 67 patients (62%) and pancytopenia in 41 patients (38%). The most common complaints were fever (63.9%), weakness (28.7%) and respiratory infection symptoms (20.3%). The most frequen tfindings on physical examination were pallor(50%), hepatomegaly (27.8%) and splenomegaly (26.8%). Thrombocytopenia was present in 86% whereas anemia and leukopenia or neutropenia were present 76.9% and 72.2%, respectively. Of the patients with bicytopenia, anemia and thrombocytopenia were present in 41.9%, leucopenia/neutropenia and thrombocytopenia were present in 37.3%, and anemia together with leukopenia/neutropenia was present in 20.8% of the patients. Bone marrow biopsy was performed in 51 patients (49.1%). The most common causes of pancytopenia/bicytopenia were infection (37.6%), acute leukemia (29.6%) and megaloblastic anemia (17.5%). Conclusion: Clinical findings, complete blood count and peripheral smear give valuable clues in patients with pancytopenia/bicytopenia. Although malignancy is the primary concern in these patients, benign conditions constitute the majority in etiology.

___

  • 1. Williams DM. Pancytopenia, Aplasticanemia and Pure redcell aplasia. In: Wintrobe’s Clinical Hematology, 10th ed. Baltimore: William andWillkins; 1993. p1449-84.
  • 2. Gnanaraj J, Parnes A, Francis CW, Go RS, Takemoto CM, Hashmi SK. Approach to pancytopenia: Diagnostic algorithm for clinical hematologists. Blood Rev 2018; 32(5): 361-7.
  • 3. Abel GA, Friese CR, Neville BA, Wilson KM, Hastings BT, Earle CC et al. Referrals for suspected hematologic malignancy: A survey of primary care physicians. Am J Hematol 2012; 87(6): 634.
  • 4. Naseem S, Varma N, Das R, Ahluwalia J, Sachdeva MU, Marwaha RK. Pediatric patients with bicytopenia/pancytopenia: Review of etiologies and clinicohematological profile at a tertiary center. Indian J Pathol Microbiol 2011; 54(1):75-80.
  • 5. Hematological reference values. In: Lanzkowsky P, Lipton JM, ed. Lanzkowsky's Manual of Pediatric Hematology and Oncology 6th Ed. Elsevier. 2016; 709-28.
  • 6. Kumar V, Khare M, Kishore M, Sharma M, Marwah S, Nigam AS et al. Diagnostic approach of new-onset pancytopenia: study from a tertiary care center. Annals of Pathology and Laboratory Medicine2018; 5(8): 641-6.
  • 7. Pizzo PA, D’Andrea AD. The Pancytopenias. In: Behrman RE, Kleigman RM, editors. Nelson Textbook of Pediatrics. 17th ed. W.B. Saunders Co; 2003: p.1642-6.
  • 8. Dosi S, Malpani G, Varma A, Malukani K, Jain PK, Ajmera A. Clinicopathological and etiological spectrum of bicytopenia/pancytopenia in children : A five year experience in a Tertiary healthcare centre. Indian J Basic ApplMedRes. 2018;7:438–46.
  • 9. Keskindemirci G, Abdullayev A, Aydoğan G, Ayaz NA, Tuğcu D, Akçay A. Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi çocuk kliniğindeki bisitopeni tanılı çocuk hastaların geriye dönük klinik ve etiyolojik değerlendirilmesi-Tek merkez deneyimi. İKSST Derg 2016; 8(2): 75-80.
  • 10. Yalaki Z, İçöz S, Arıkan Fİ, Alioğlu B, Dallar YB. Our experience with bicytopenia in patients treated at the Ankara Hospital Pediatric Clinic. J Pediatr Inf 2014; 8: 23-7.
  • 11. Dubey SRS, Patel SK, Arya AK, Singh RP. Clinico-etiological spectrum of pancytopenia in hospitalized children. Int J Contemp Pediatr 2016; 3(1):169-72.
  • 12. Karavanaki K, Polychronopoulou S, Giannaki M, Haliotis F, Sider F, Brisimitzi M et al. Transient and chronic neutropenias detected in children with different viral and bacterial infections. Acta Paediatr 2006; 95(5): 565-72.
  • 13. Alexandropoulou O, Kossiva L, Giannaki M, Panagiotou J, Tsolia M, Karavanaki K. Theepidemiology, clinicalcourseandoutcome of febrilecytopenia in children.ActaPaediatr 2015;104(3):112–8.
  • 14. Alexandropoulou O, Kossiva L, Haliotis F, Giannaki M, Tsolia M, Panagiotou IP et al. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up. Eur J Pediatr 2013; 172 (6): 811-9.
  • 15. Gupta A, Bhatnagar R, Prasad PL. Peripheral cytopenia in children: a hospital-based study. Int J Contemp Pediatr. 2020; 7(1):84-9.
  • 16. Sharif M, Masood N, ZahoorulHaq M, Dodhy MA, Asghar RM. Etiological spectrum of pancytopenia / bicytopenia in children 2 months to 12 years of age. Journal of Rawalpindi Medical College (JRMC) 2014;18(1): 61-4.
  • 17. GuptaV, Tripathi S, Tilak V, Bhatia BD. A study of clinico-haematological profiles of pancytopenia in children. Trop Doct 2008; 38(4): 241-3.
  • 18. Gupta M, Chandna A, Kumar S, Kataria SP, Hasija S, Singh G et al. Clinicohematological profile of pancytopenia: a study from a tertiary care hospital. Dicle Medical Journal 2016; 43 (1): 5-11.
  • 19. Bhatnagar SK, Chandra J, Narayan S, Sharma S, Singh V, Dutta A. Pancytopenia in children: Etiological profile. J Trop Pediatr 2005; 51(4): 236-9.
  • 20. Memon S, Shaikh S, Nizamani MA. Etiological spectrum of pancytopenia based on bone marrow examination in children. J Coll Physicians Surg Pak 2008; 18(3): 163-7.
  • 21. Jan AZ, Zahid B, Ahmad S, Gul Z. Pancytopenia in children: A 6-year spectrum of patients admitted to Pediatric Department of Rehman Medical Institute, Peshawar. Pak J MedSci. 2013; 29(5): 1153–7.
  • 22. Hassan BJ, Campos MP. Iron deficiency thrombocytopenia: A case report and review of the literature. J Clin Case Rep 2018; 8:3.
  • 23. MorrisVK,Spraker HL, Howard SC, Ware RE, Reis UM. Severe thrombocytopenia with iron deficiency anemia. Pediatr Hematol Oncol. 2010; 27(5): 413–9.
  • 24. Kuku I, Kaya E, Yologlu S, Gokdeniz R, Baydin A. Platelet counts in adults with iron deficiency anemia. Platelets 2009; 20(6): 401-5.
İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi-Cover
  • ISSN: 1305-5151
  • Başlangıç: 1995
  • Yayıncı: İzmir Bozyaka Eğitim ve Araştırma Hastanesi
Sayıdaki Diğer Makaleler

İKİNCİ TRİMESTER MATERNAL SERUM BELİRTEÇLERİNİN SAĞLIKLI GEBELERDE DOĞUM ZAMANINI ÖNGÖRMEDEKİ ROLÜ

Aysegul GULBAHAR, Seda AKGUN KAVURMACI

COVID-19 PANDEMİSİNİN ACİL GENEL CERRAHİ VE ELEKTİF ONKOLOJİK CERRAHİ AMELİYATLARINA ETKİSİ: RETROSPEKTİF KESİTSEL ÇALIŞMA

Abdullah DURHAN, Abdullah ŞENLİKC, Rıfat BEZİRC, Marlen SÜLEYMAN, Koray KOŞMAZ, Yusuf Murat BAĞ, Ümit MERCAN, Mevlüt Recep PEKÇİC

CANLI VERİCİLİ BÖBREK NAKLİ DONÖRLERİMİZİN UZUN DÖNEMLİ TAKİP SONUÇLARI

Cenk ŞİMŞEK, Murat KARATAŞ

AİLESEL AKDENİZ ATEŞİ TANISI İLE İZLENEN OLGULARIN ÜST GASTROİNTESTİNAL SİSTEM BULGULARININ DEĞERLENDİRİLMESİ

Gizem SARI, Nafiye URGANCI, Gül ÖÇELİK, Merve USTA

DEPREM SONRASI GÖÇ EDEN ERGENLERDE GERİLİM TİPİ BAŞ AĞRISI: KONTROLLÜ ÇALIŞMA

Edip GÖNÜLLÜ, Hande Gazeteci TEKİN

THE EFFICACY OF HYDROXYCHLOROQUINE IN HOSPITALIZED COVID-19 POSITIVE PATIENTS

Şükran KÖSE, Gözde DERVİŞ HAKİM, Melda TÜRKEN, Pelin ADAR, Sabri ATALAY, Kamil MERT, Bengü Gireniz TATAR

RABDOMİYOLİZE BAĞLI AKUT BÖBREK YETMEZLİĞİ GELİŞEN HASTALARIN, KARAKTERİSTİK ÖZELLİKLERİ VE RİSK FAKTÖRLERİ: TEK MERKEZ DENEYİMİ

Mine Şebnem KARAKAN, Beyza ALGÜL DURAK

HASTANEYE YATAN COVID-19 POZİTİF HASTALARDA HİDROKSİKLOROKİNİN ETKİNLİĞİ

Bengü GİRENİZ TATAR, Sabri ATALAY, Melda TÜRKEN, Pelin ADAR, Gözde DERVİŞ HAKİM, Şükran KÖSE, Kamil MERT

MEME KANSERİ GELİŞİMİNDEKİ PROGNOSTİK FAKTÖRLER: ERKEN VE GEÇ EVRE KANSERLERİN KARŞILAŞTIRILMASI

Cenk ŞİMŞEK, Murat KARATAŞ, Baha ZENGEL

6 HAFTA- 1 YAŞ BEBEĞİ OLAN ANNELERDE POSTPARTUM DEPRESYON SIKLIĞI VE İLİŞKİLİ SOSYODEMOGRAFİK RİSK FAKTÖRLERİ

Hilal AKSOY, Öznur ŞAHİN, Esra Meltem KOÇ